Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?

Int Immunopharmacol. 2022 Jul:108:108896. doi: 10.1016/j.intimp.2022.108896. Epub 2022 May 28.

Abstract

Viruses may transform infected cells into benign or malignant tumors, promoting cell growth and survival via various intracellular pathways. Some oncogenic DNA viruses, such as human papillomaviruses, can lead to squamous intraepithelial lesions and cervical cancer. Furthermore, the early HPV virus'soncoproteins have been attributed to cancer initiation and development and tumor-enhancing action. In addition to viral oncoproteins, antigen-presenting cells (APC) and the number of clusters of differentiation (CD) markers expressed on their surface play an essential role in disease progression or tumorigenesis inhibition. This article discussed the function of CD markers in the interaction between APCs and cancer cells, immune cells' function in the infection process, and finally infected cells' malignancy. We investigated targeting these markers as a novel insight to create a new therapeutic or diagnosis strategy to prevent cervical cancer progression.

Keywords: Antigen-presentingcells; B cell; Cluster of differentiation; Dendritic cells; Human papillomavirus; Macrophage.

Publication types

  • Review

MeSH terms

  • Antigen-Presenting Cells
  • Female
  • Humans
  • Papillomaviridae / genetics
  • Papillomavirus Infections*
  • Prognosis
  • Uterine Cervical Neoplasms* / pathology